115055-A prospective study to estimate the incidence of diseases specified as adverse events of special interest, of other adverse events leading to hospitalisation or death, and of meningitis in infants and young children in sub-Saharan Africa prior to implementation of the RTS,S/AS01E candidate vaccine (EPI-MALARIA 002 VS AME)

20/01/2022
23/04/2024
EU PAS number:
EUPAS45288
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.42 MB - PDF) View document
Study results
Study report
Other information